MAX IV anniversary: 10 years of 4th generation brilliance, 40 years of scientific excellence

News from MAX IV
Industry

Accelerating cancer drug discovery at BioMAX

Supported by advanced structural biology capabilities at MAX IV, Acrivon Therapeutics advanced a novel cancer drug candidate from initial lead identification to clinical development in only 15 months.

More news chevron_right

Guided by the light?

Come work with us!

The opportunity to a be part of building MAX IV is for many enough reason to join our team. But aside from tinkering with all our stunning technology, we also offer a wide array of benefits to everyone of our employees.

Vacancies at MAX IV chevron_right